COYA coyatherapeutics.com: Narxning prognoz qilingan daromadga nisbati

Coya (COYA) kompaniyasining rasmiy ramzlari

Coya Therapeutics, Inc. (COYA) uchun forward narx-savdo ko'rsatkichining baholash tendentsiyasi sovitish zanjiri logistikasining hujayra terapiyasiga ta'sirini namoyish etadi, 14.90 esa ushbu ko'rsatkichning joriy qiymatini aks ettiradi. Geopolitik keskinliklar va sanksiyalar dori vositalarining sertifikatsiyasiga hamda xalqaro tadqiqotlarga to'sqinlik qilmoqda. Shu bilan birga, ALS va Altsgeymer kasalliklarini davolashga bo'lgan talabning ortishi strategik farmatsevtika hamkorlarini izlashni jadallashtirmoqda.

Coya Therapeutics Inc - COYA Forvard P/S multiplikatori (davr: 21.03.2024 - 17.11.2026)

COYA (Coya): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning fundamental tahlili:Coya (COYA)
Coya Therapeutics Inc tovar namunasi

Oldingi P/S koeffitsiyenti biznesning bozor qiymatini kutilayotgan daromadga nisbatan baholaydi, bu esa investorlarga mablag'lar haqiqatda qabul qilinishidan oldin aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlash imkonini beradi. Prognozlarga asoslangan oldingi P/S dinamikasi kapitalizatsiyaning biomateriallar logistikasining samaradorligiga sezgirligini aks ettiradi, chunki Coya Therapeutics (COYA) uchun molekulalarni tashishdagi har qanday uzilishlar dori vositalarini tijoratlashtirish ehtimolini va kutilayotgan daromadlarni bevosita kamaytiradi.

Raqobatdosh kompaniyalar

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|vistagen.com - Forvard P/S multiplikatori|OVID: Narxning prognoz qilingan daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning prognoz qilingan daromadga nisbati|CervoMed Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PEPG (PepGen Inc)|Forvard P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning prognoz qilingan daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori